Total, Dialyzable, and Nondialyzable Postabsorptive Hydroxyproline: Values in Patients With Cancer

Harvey B. Niell, Genaro M. Palmieri, Charles L. Neely, Theresa A. Maxwell, Stanley C. Hopkins, Mark S. Soloway

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The postabsorptive urinary total (T), dialyzable (D), and nondialyzable (ND) hydroxyproline (HYPRO) tests were evaluated to determine whether the patterns of excretion varied according to the predominance of osteoblastic v osteolytic bone involvement in 58 patients with neoplastic disease. In patients with osteolytic lesions from multiple myeloma, elevated T and D levels with normal ND HYPRO values were observed, along with elevated D/ND ratios. In prostate cancer, the T, D, and ND values were all elevated and the D/ND ratio was normal. Patients with Hodgkin's disease had elevated T, D, and ND HYPRO levels, and the D/ND ratio was in the range of patients with prostate cancer. The data suggest that these collagen markers may be useful in the long-term evaluation of these neoplasms in patients.

Original languageEnglish (US)
Pages (from-to)1925-1927
Number of pages3
JournalArchives of Internal Medicine
Volume143
Issue number10
DOIs
StatePublished - 1983
Externally publishedYes

Fingerprint

Hydroxyproline
Neoplasms
Prostatic Neoplasms
Multiple Myeloma
Hodgkin Disease
Collagen
Bone and Bones

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Niell, H. B., Palmieri, G. M., Neely, C. L., Maxwell, T. A., Hopkins, S. C., & Soloway, M. S. (1983). Total, Dialyzable, and Nondialyzable Postabsorptive Hydroxyproline: Values in Patients With Cancer. Archives of Internal Medicine, 143(10), 1925-1927. https://doi.org/10.1001/archinte.1983.00350100097020

Total, Dialyzable, and Nondialyzable Postabsorptive Hydroxyproline : Values in Patients With Cancer. / Niell, Harvey B.; Palmieri, Genaro M.; Neely, Charles L.; Maxwell, Theresa A.; Hopkins, Stanley C.; Soloway, Mark S.

In: Archives of Internal Medicine, Vol. 143, No. 10, 1983, p. 1925-1927.

Research output: Contribution to journalArticle

Niell, HB, Palmieri, GM, Neely, CL, Maxwell, TA, Hopkins, SC & Soloway, MS 1983, 'Total, Dialyzable, and Nondialyzable Postabsorptive Hydroxyproline: Values in Patients With Cancer', Archives of Internal Medicine, vol. 143, no. 10, pp. 1925-1927. https://doi.org/10.1001/archinte.1983.00350100097020
Niell, Harvey B. ; Palmieri, Genaro M. ; Neely, Charles L. ; Maxwell, Theresa A. ; Hopkins, Stanley C. ; Soloway, Mark S. / Total, Dialyzable, and Nondialyzable Postabsorptive Hydroxyproline : Values in Patients With Cancer. In: Archives of Internal Medicine. 1983 ; Vol. 143, No. 10. pp. 1925-1927.
@article{27788aabbbfd47d2ad49a38ae25935fb,
title = "Total, Dialyzable, and Nondialyzable Postabsorptive Hydroxyproline: Values in Patients With Cancer",
abstract = "The postabsorptive urinary total (T), dialyzable (D), and nondialyzable (ND) hydroxyproline (HYPRO) tests were evaluated to determine whether the patterns of excretion varied according to the predominance of osteoblastic v osteolytic bone involvement in 58 patients with neoplastic disease. In patients with osteolytic lesions from multiple myeloma, elevated T and D levels with normal ND HYPRO values were observed, along with elevated D/ND ratios. In prostate cancer, the T, D, and ND values were all elevated and the D/ND ratio was normal. Patients with Hodgkin's disease had elevated T, D, and ND HYPRO levels, and the D/ND ratio was in the range of patients with prostate cancer. The data suggest that these collagen markers may be useful in the long-term evaluation of these neoplasms in patients.",
author = "Niell, {Harvey B.} and Palmieri, {Genaro M.} and Neely, {Charles L.} and Maxwell, {Theresa A.} and Hopkins, {Stanley C.} and Soloway, {Mark S.}",
year = "1983",
doi = "10.1001/archinte.1983.00350100097020",
language = "English (US)",
volume = "143",
pages = "1925--1927",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "10",

}

TY - JOUR

T1 - Total, Dialyzable, and Nondialyzable Postabsorptive Hydroxyproline

T2 - Values in Patients With Cancer

AU - Niell, Harvey B.

AU - Palmieri, Genaro M.

AU - Neely, Charles L.

AU - Maxwell, Theresa A.

AU - Hopkins, Stanley C.

AU - Soloway, Mark S.

PY - 1983

Y1 - 1983

N2 - The postabsorptive urinary total (T), dialyzable (D), and nondialyzable (ND) hydroxyproline (HYPRO) tests were evaluated to determine whether the patterns of excretion varied according to the predominance of osteoblastic v osteolytic bone involvement in 58 patients with neoplastic disease. In patients with osteolytic lesions from multiple myeloma, elevated T and D levels with normal ND HYPRO values were observed, along with elevated D/ND ratios. In prostate cancer, the T, D, and ND values were all elevated and the D/ND ratio was normal. Patients with Hodgkin's disease had elevated T, D, and ND HYPRO levels, and the D/ND ratio was in the range of patients with prostate cancer. The data suggest that these collagen markers may be useful in the long-term evaluation of these neoplasms in patients.

AB - The postabsorptive urinary total (T), dialyzable (D), and nondialyzable (ND) hydroxyproline (HYPRO) tests were evaluated to determine whether the patterns of excretion varied according to the predominance of osteoblastic v osteolytic bone involvement in 58 patients with neoplastic disease. In patients with osteolytic lesions from multiple myeloma, elevated T and D levels with normal ND HYPRO values were observed, along with elevated D/ND ratios. In prostate cancer, the T, D, and ND values were all elevated and the D/ND ratio was normal. Patients with Hodgkin's disease had elevated T, D, and ND HYPRO levels, and the D/ND ratio was in the range of patients with prostate cancer. The data suggest that these collagen markers may be useful in the long-term evaluation of these neoplasms in patients.

UR - http://www.scopus.com/inward/record.url?scp=84948011740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948011740&partnerID=8YFLogxK

U2 - 10.1001/archinte.1983.00350100097020

DO - 10.1001/archinte.1983.00350100097020

M3 - Article

AN - SCOPUS:84948011740

VL - 143

SP - 1925

EP - 1927

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 10

ER -